C=C1C(=O)O[C@H]2C[C@]3(C)C[C@H](O)CC(=C)[C@H]3C[C@@H]12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?